ArticleJournal of the Pediatric Infectious Diseases Society2012

Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial.

Joanne M Langley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.